Leave your contact details and we will contact you
By the end of 2025, Russian consumers purchased nearly 12 million packs of contact lens solutions across all retail distribution channels, spending a total of RUB 5.4 billion (at retail prices, including VAT). Compared with 2024, sales in this category increased by 19.4% in value terms and by 14% in packs. In 2024 versus 2023, value growth had been significantly lower (+8.4%), while physical consumption increased by 6.2%.
The role of e-commerce in the segment of contact lens cleaning and storage solutions continues to grow steadily. In 2025, the value growth of online sales reached +35%, which is 3.5 times higher than the growth rate recorded in traditional retail outlets. According to data from the RNC Pharma database Audit of Retail Sales of Ophthalmic Products in Russia (total sell out), the combined value share of marketplaces in the reporting period reached 41.7%, compared with no more than 36.9% a year earlier. Based on RNC Pharma estimates, the bulk of online sales is generated by Ozon and Wildberries. At the same time, the role of pharmacies in this category continued to decline: while in 2022 this channel accounted for 55% of sales, in 2025 its share did not exceed 42.9%. A further 15.4% of value sales is generated by specialised optical stores, which is also significantly lower than three years ago, with the share decreasing by 8.3 percentage points over that period.
During the reporting period, products in this category were supplied by more than 30 companies. In total, the market included around 50 brands comprising 252 SKUs. Notably, nearly 45% of total value sales in the category are generated by two leading US companies—Bausch Health and Alcon Laboratories—which together offer more than 20 SKUs of contact lens solutions on the Russian retail market.
Over the past two years, approximately 19 new products have entered the retail market in this category, most of them manufactured in South Korea and Russia. In 2025, the top ten products accounted for more than 82% of total value sales. The highest consumer spending was recorded for the Renu brand by Bausch Health, which held a 20.1% value share. The second position was retained by Opti-Free from Alcon Laboratories; however, the brand’s share has been gradually declining over several years and amounted to 11.2% in 2025. Third place was taken by Aquaoptik from the Russian manufacturer Grotex, which accounted for 10.3% of value sales during the period. Compared with 2024, sales of this brand decreased by 1.4% in value terms. At the same time, the company has several other brands in the category, some of which demonstrated outstanding performance. In particular, value sales of the Mizrin brand, introduced to the market in 2024, increased 73-fold year on year.
Among leading products, the highest growth rates were recorded for Okvision by OK Vision and Biotrue by Bausch Health, with value sales of both brands doubling year on year. Acuvue by Johnson & Johnson, which ranked fifth, also demonstrated stable growth. Over the past three years, the brand has shown double-digit growth rates in both value and volume terms, and compared with 2024 its sales increased by 24% both in value and in packs.
| № | Brand | Company | Share in 2025, %, RUB | Dynamics vs. 2024, %, RUB |
| 1 | Renu | Bausch Health | 20.1 | 39 |
| 2 | Opti-Free | Alcon Laboratories | 11.2 | 1 |
| 3 | Aquaoptik | Grotex | 10.3 | -1 |
| 4 | AOSept | Alcon Laboratories | 8.7 | 21 |
| 5 | Acuvue | Johnson & Johnson | 8.4 | 24 |
| 6 | Likontin | Medstar | 7.6 | 3 |
| 7 | Avizor | Avizor | 5.0 | 13 |
| 8 | Optimed | Optimedservice | 3.8 | 22 |
| 9 | Okvision | OK Vision | 3.7 | 101 |
| 10 | Biotrue | Bausch Health | 3.5 | 110 |
| Source: RNC Pharma®, Audit of Retail Sales of Ophthalmic Products in Russia (total sell out) | ||||
Leave your contact details and we will contact you